Long-term survival after gamma knife radiosurgery in a case of recurrent glioblastoma multiforme: A case report and review of the literature

Case Reports in Medicine

Volumn 2012, Issue , 2012, Pages

  Thumma, Sudheer R ^a,b   Elaimy, Ameer L ^a,b   Daines, Nathan ^a,b   MacKay, Alexander R ^a,c   Lamoreaux, Wayne T ^a,b   Fairbanks, Robert K ^a,b   Demakas, John J ^a,d   Cooke, Barton S ^a   Lee, Christopher M ^a,b  

^a Gamma Knife of Spokane   (United States)

^b Cancer Care Northwest   (United States)

^c Mackay and Meyer MDs   (United States)

^d Spokane Brain and Spine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TEMOZOLOMIDE;

ADULT; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CASE REPORT; CHEMORADIOTHERAPY; DRUG WITHDRAWAL; EXTERNAL BEAM RADIOTHERAPY; GAMMA KNIFE RADIOSURGERY; GLIOBLASTOMA; HUMAN; LOCAL THERAPY; LONGEVITY; MALE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT CANCER; SURVIVAL TIME; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 84883688418     PISSN: 16879627     EISSN: 16879635     Source Type: Journal    
DOI: 10.1155/2012/545492     Document Type: Article

References (44)

1. Deorah S., Lynch C. F., Sibenaller Z. A., Ryken T. C., Trends in brain cancer incidence and survival in the United States: surveillance, epidemiology, and end results program, 1973 to 2001 Neurosurgical Focus 2006 20 4, article E1
2. Hess K. R., Broglio K. R., Bondy M. L., Adult glioma incidence trends in the United States, 19772000 Cancer 2004 101 10 2293 2299 (Pubitemid 39458686)
3. Polednak A. P., Flannery J. T., Brain, other central nervous system, and eye cancer Cancer 1995 75 1 330 337
4. Salcman M., Kaplan R. S., Samaras G. M., Aggressive multimodality therapy based on a multicompartmental model of glioblastoma Surgery 1982 92 2 250 259 (Pubitemid 13091509)
5. Gerstein J., Franz K., Steinbach J. P., Seifert V., Fraunholz I., Weiss C., Rodel C., Postoperative radiotherapy and concomitant temozolomide for elderly patients with glioblastoma Radiotherapy and Oncology 2010 97 3 382 386
6. Hollerhage H. G., Zumkeller M., Becker M., Dietz H., Influence of type and extent of surgery on early results and survival time in glioblastoma multiforme Acta Neurochirurgica 1991 113 1-2 31 37
7. Affronti M. L., Heery C. R., Herndon J. E. II, Rich J. N., Reardon D. A., Desjardins A., Vredenburgh J. J., Friedman A. H., Bigner D. D., Friedman H. S., Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy Cancer 2009 115 15 3501 3511
8. Ashby L., LaRocca R., Ryken T., Treatment of brain tumors New England Journal of Medicine 2005 352 22 2350 2353 (Pubitemid 40740562)
9. Smith K. A., Ashby L. S., Gonzalez F., Brachman D. G., Thomas T., Coons S. W., Battaglia M., Scheck A., Prospective trial of gross-total resection with Gliadel wafers followed by early postoperative Gamma Knife radiosurgery and conformal fractionated radiotherapy as the initial treatment for patients with radiographically suspected, newly diagnosed glioblastoma multiforme Journal of Neurosurgery 2008 109 106 117
10. Tatter S. B., Recurrent malignant glioma in adults Current Treatment Options in Oncology 2002 3 6 509 524
11. Friedman H. S., Prados M. D., Wen P. Y., Mikkelsen T., Schiff D., Abrey L. E., Yung W. K. A., Paleologos N., Nicholas M. K., Jensen R., Vredenburgh J., Huang J., Zheng M., Cloughesy T., Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma Journal of Clinical Oncology 2009 27 28 4733 4740
12. Brandes A. A., State-of-the-art treatment of high-grade brain tumors Seminars in Oncology 2003 30 6 supplement 19 4 9 (Pubitemid 38199156)
13. Fokas E., Wacker U., Gross M. W., Henzel M., Encheva E., Engenhart-Cabillic R., Hypofractionated stereotactic reirradiation of recurrent glioblastomas: a beneficial treatment option after high-dose radiotherapy? Strahlentherapie und Onkologie 2009 185 4 235 240
14. Gabayan A. J., Green S. B., Sanan A., Jenrette J., Schultz C., Papagikos M., Tatter S. P., Patel A., Amin P., Lustig R., Bastin K. T., Watson G., Burri S., Stea B., GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis Neurosurgery 2006 58 4 701 709
15. Minniti G., Armosini V., Salvati M., Lanzetta G., Caporello P., Mei M., Osti M. F., Maurizi R. E., Fractionated stereotactic reirradiation and concurrent temozolomide in patients with recurrent glioblastoma Journal of Neurooncology 2010 103 3 689 691
16. Patel M., Siddiqui F., Jin J. Y., Mikkelsen T., Rosenblum M., Movsas B., Ryu S., Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival Journal of Neurooncology 2009 92 2 185 191
17. Cho K. H., Hall W. A., Gerbi B. J., Higgins P. D., McGuire W. A., Clark H. B., Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas International Journal of Radiation Oncology Biology Physics 1999 45 5 1133 1141
18. Cho K. H., Hall W. A., Lo S. S., Dusenbery K. E., Stereotactic radiosurgery versus fractionated stereotactic radiotherapy boost for patients with glioblastoma multiforme Technology in Cancer Research and Treatment 2004 3 1 41 49 (Pubitemid 38250467)
19. Combs S. E., Thilmann C., Edler L., Debus J., Schulz-Ertner D., Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution Journal of Clinical Oncology 2005 23 34 8863 8869 (Pubitemid 46211533)
20. Combs S. E., Widmer V., Thilmann C., Hof H., Debus J., Schulz-Ertner D., Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM) Cancer 2005 104 10 2168 2173 (Pubitemid 41579963)
21. Park J. K., Hodges T., Arko L., Shen M., Dello Iacono D., McNabb A., Olsen Bailey N., Kreisl T. N., Iwamoto F. M., Sul J., Auh S., Park G. E., Fine H. A., Black P. M., Scale to predict survival after surgery for recurrent glioblastoma multiforme Journal of Clinical Oncology 2010 28 24 3838 3843
22. Phuphanich S., Ferrall S., Greenberg H., Long-term survival in malignant glioma. Prognostic factors Journal of the Florida Medical Association 1993 80 3 181 184 (Pubitemid 23140542)
23. Glas M., Happold C., Rieger J., Herrlinger U., Wiewrodt D., Bixhr O., Steinbach J. P., Wick W., Kortmann R. D., Reifenberger G., Weller M., Long-term survival of patients with glioblastoma treated with radiotherapy and lomustine plus temozolomide Journal of Clinical Oncology 2009 27 8 1257 1261
24. Layfield L. J., Willmore C., Tripp S., Jones C., Jensen R. L., Epidermal growth factor receptor gene amplification and protein expression in glioblastoma multiforme: prognostic significance and relationship to other prognostic factors Applied Immunohistochemistry and Molecular Morphology 2006 14 1 91 96
25. Tripp S. R., Willmore-Payne C., Layfield L. J., Relationship between EGFR overexpression and gene amplification status in central nervous system gliomas Analytical and Quantitative Cytology and Histology 2005 27 2 71 78 (Pubitemid 40563156)
26. Bleeker F. E., Atai N. A., Lamba S., Jonker A., Rijkeboer D., Bosch K. S., Tigchelaar W., Troost D., van Dertop W. P., Bardelli A., van Noorden C. J. F., The prognostic IDH1R132 mutation is associated with reduced NADP + -dependent IDH activity in glioblastoma Acta Neuropathologica 2010 119 4 487 494
27. Boldrini L., Pistolesi S., Gisfredi S., Ursino S., Ali G., Pieracci N., Basolo F., Parenti G., Fontanini G., Telomerase activity and hTERT mRNA expression in glial tumors International Journal of Oncology 2006 28 6 1555 1560
28. Donato V., Papaleo A., Castrichino A., Banelli E., Glangaspero F., Salvati M., Delfini R., Prognostic implication of clinical and pathologic features in patients with glioblastoma multiforme treated with concomitant radiation plus temozolomide Tumori 2007 93 3 248 256 (Pubitemid 47080010)
29. Umesh S., Tandon A., Santosh V., Anandh B., Sampath S., Chandramouli B. A., Sastry Kolluri V. R., Clinical and immunohistochemical prognostic factors in adult glioblastoma patients Clinical Neuropathology 2009 28 5 362 372
30. Quant E. C., Drappatz J., Wen P. Y., Norden A. D., Recurrent high-grade glioma Current Treatment Options in Neurology 2010 12 4 321 333
31. Schmidt F., Fischer J., Herrlinger U., Dietz K., Dichgans J., Weller M., PCV chemotherapy for recurrent glioblastoma Neurology 2006 66 4 587 589 (Pubitemid 43739895)
32. Chamberlain M. C., Salvage chemotherapy with CPT-11 for recurrent glioblastoma multiforme Journal of Neurooncology 2002 56 2 183 188 (Pubitemid 34272310)
33. Minniti G., Muni R., Lanzetta G., Marchetti P., Maurizi Enrici R., Chemotherapy for glioblastoma: current treatment and future perspectives for cytotoxic and targeted agents Anticancer Research 2009 29 12 5171 5184
34. Stupp R., Hegi M. E., van den Bent M. J., Mason W. P., Weller M., Mirimanoff R. O., Cairncross J. G., Changing paradigmsan update on the multidisciplinary management of malignant glioma Oncologist 2006 11 2 165 180 (Pubitemid 43261763)
35. Trent S., Kong A., Short S. C., Traish D., Ashley S., Dowe A., Hines F., Brada M., Temozolomide as second-line chemotherapy for relapsed gliomas Journal of Neurooncology 2002 57 3 247 251 (Pubitemid 34692633)
36. Galanis E., Buckner J. C., Maurer M. J., Kreisberg J. I., Ballman K., Boni J., Peralba J. M., Jenkins R. B., Dakhil S. R., Morton R. F., Jaeckle K. A., Scheithauer B. W., Dancey J., Hidalgo M., Walsh D. J., Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study Journal of Clinical Oncology 2005 23 23 5294 5304 (Pubitemid 46206983)
37. Peereboom D. M., Shepard D. R., Ahluwalia M. S., Brewer C. J., Agarwal N., Stevens G. H. J., Suh J. H., Toms S. A., Vogelbaum M. A., Weil R. J., Elson P., Barnett G. H., Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme Journal of Neurooncology 2010 98 1 93 99
38. Study J. J., HER1/EGFR tyrosine kinase inhibitors for the treatment of glioblastoma multiforme Journal of Neurooncology 2005 74 1 77 86 (Pubitemid 41194535)
39. Terasaki M., Shibui S., Narita Y., Fujimaki T., Aoki T., Kajiwara K., Sawamura Y., Kurisu K., Mineta T., Yamada A., Itoh K., Phase I trial of a personalized peptide vaccine for patients positive for human leukocyte antigen-A24 with recurrent or progressive glioblastoma multiforme Journal of Clinical Oncology 2011 29 3 337 344
40. Moviglia G. A., Carrizo A. G., Varela G., Gaeta C. A., Paes de Lima A., Farina P., Molina H., Preliminary report on tumor stem cell/B cell hybridoma vaccine for recurrent glioblastoma multiforme Hematology/Oncology and Stem Cell Therapy 2008 1 1 3 13
41. Chino K., Silvain D., Grace A., Stubbs J., Stea B., Feasibility and safety of outpatient brachytherapy in 37 patients with brain tumors using the GliaSite radiation therapy system Medical Physics 2008 35 7 3383 3388 (Pubitemid 351904541)
42. Chamberlain M. C., Barba D., Kormanik P., Shea W. M. C., Stereotactic radiosurgery for recurrent gliomas Cancer 1994 74 4 1342 1347 (Pubitemid 24301790)
43. Souhami L., Seiferheld W., Brachman D., Podgorsak E. B., Werner-Wasik M., Lustig R., Schultz C. J., Sause W., Okunieff P., Buckner J., Zamorano L., Mehta M. P., Curran W. J., Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol International Journal of Radiation Oncology Biology Physics 2004 60 3 853 860 (Pubitemid 39311766)
44. Villavicencio A. T., Burneikiene S., Romanelli P., Fariselli L., McNeely L., Lipani J. D., Chang S. D., Nelson E. L., McIntyre M., Broggi G., Adler J. R., Survival following stereotactic radiosurgery for newly diagnosed and recurrent glioblastoma multiforme: a multicenter experience Neurosurgical Review 2009 32 4 417 424